Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers - Mundt, F; Rajput, S; Li, S; Ruggles, K V; Mooradian, A D; Mertins, P (2018)
Cancer Res